Terms: = Kidney tumors AND TRIM27, DASS-46L4_6, RFP, 5987, ENSG00000234495, RNF76 AND Staging
490 results:
1. Nomogram for personalized prognostic assessment of children with favorable histology Wilms tumor: A retrospective analysis.
Wang Z; Li J; Liu P; Xie X; Song H; Zhang W
Urol Oncol; 2024 Jun; 42(6):178.e1-178.e10. PubMed ID: 38522976
[TBL] [Abstract] [Full Text] [Related]
2. Unveiling the challenges of UTUC biopsies and cytology: insights from a global real-world practice study.
Baard J; Cormio L; Dasgupta R; Maruzzi D; Rais-Bahrami S; Serrano A; Geavlete B; Giannakopoulos S; de la Rosette J; Laguna P
World J Urol; 2024 Mar; 42(1):177. PubMed ID: 38507109
[TBL] [Abstract] [Full Text] [Related]
3. Applicability and feasibility of robot-assisted cystectomy and intracorporeal urinary diversion in a patient with right renal pelvic ectopia.
Puliatti S; Ferretti S; Peñaranda NR; Eissa A; Ticonosco M; De Faveri A; De Carne C; Wisz P; Ferrari R; Tosi G; Annino F; Bianchi G; Micali S
Int Braz J Urol; 2024; 50(2):227-228. PubMed ID: 38386794
[TBL] [Abstract] [Full Text] [Related]
4. Prognostic significance of pT3a staging subclassifications in renal cell carcinoma: Not all pT3a are equal.
Rezaee ME; Pallauf M; Fletcher SA; Pavlovich CP; Baraban E; Ged Y; Singla N
Urol Oncol; 2024 Apr; 42(4):119.e23-119.e29. PubMed ID: 38355353
[TBL] [Abstract] [Full Text] [Related]
5. Combined visual and quantitative assessment of somatostatin receptor scintigraphy for staging and restaging of neuroendocrine tumors.
Ueki Y; Otsuka H; Otani T; Kasai R; Otomi Y; Ikemitsu D; Azane S; Kunikane Y; Bando T; Matsuda N; Okada Y; Takayama T; Harada M
Jpn J Radiol; 2024 May; 42(5):519-535. PubMed ID: 38345724
[TBL] [Abstract] [Full Text] [Related]
6. Unraveling the BMI paradox in different renal cortical tumors: insights from the INMARC registry.
Saitta C; Afari JA; Walia A; Patil D; Tanaka H; Hakimi K; Wang L; Meagher MF; Liu F; Nguyen MV; Puri D; Cerrato C; Saidian A; Kobayashi M; Fukuda S; Fujii Y; Master V; Derweesh IH
Urol Oncol; 2024 Apr; 42(4):119.e1-119.e16. PubMed ID: 38341362
[TBL] [Abstract] [Full Text] [Related]
7. Natural small-molecules reverse Xeroderma Pigmentosum Complementation Group C (XPC) deficient-mediated drug-resistance in renal cell carcinoma.
Chen R; Lo HH; Yang C; Law BYK; Chen X; Lam CCI; Ho C; Cheong HL; Li Q; Zhong C; Ng JPL; Peter CKF; Wong VKW
Phytomedicine; 2024 Feb; 124():155310. PubMed ID: 38215574
[TBL] [Abstract] [Full Text] [Related]
8. Omission of adjuvant chemotherapy in patients with completely necrotic Wilms tumor stage I and radiotherapy in stage III: The 30-year SIOP-RTSG experience.
Vujanić GM; Graf N; D'Hooghe E; Pritchard-Jones K; Bergeron C; Tinteren HV; Furtwängler R;
Pediatr Blood Cancer; 2024 Mar; 71(3):e30852. PubMed ID: 38185745
[TBL] [Abstract] [Full Text] [Related]
9. Single-Port Robotic Radical Prostatectomy Using Transvesical and Transperineal Access in Patients with a Hostile Abdomen.
Ferguson EL; Ramos-Carpinteyro R; Soputro N; Chavali JS; Geskin A; Kaouk JH
J Endourol; 2024 Feb; 38(2):150-158. PubMed ID: 38069569
[No Abstract] [Full Text] [Related]
10. [Renal tumors in children and adolescents].
Tsiflikas I
Radiologie (Heidelb); 2024 Jan; 64(1):18-25. PubMed ID: 37947863
[TBL] [Abstract] [Full Text] [Related]
11. Novel Use of Circulating Tumor DNA to Identify Muscle-invasive and Non-organ-confined Upper Tract Urothelial Carcinoma.
Huelster HL; Gould B; Schiftan EA; Camperlengo L; Davaro F; Rose KM; Soupir AC; Jia S; Zheng T; Sexton WJ; Pow-Sang J; Spiess PE; Daniel Grass G; Wang L; Wang X; Vosoughi A; Necchi A; Meeks JJ; Faltas BM; Du P; Li R
Eur Urol; 2024 Mar; 85(3):283-292. PubMed ID: 37802683
[TBL] [Abstract] [Full Text] [Related]
12. Biochemical Recurrence and Risk of Mortality Following Radiotherapy or Radical Prostatectomy.
Falagario UG; Abbadi A; Remmers S; Björnebo L; Bogdanovic D; Martini A; Valdman A; Carrieri G; Menon M; Akre O; Eklund M; Nordström T; Grönberg H; Lantz A; Wiklund P
JAMA Netw Open; 2023 Sep; 6(9):e2332900. PubMed ID: 37695584
[TBL] [Abstract] [Full Text] [Related]
13. Sarcopenia assessments as predictors of overall survival in patients with metastatic renal cell carcinoma.
Kümmerl L; Kraulich M; Lesyuk W; Binninger A; Goebell PJ; Kahlmeyer A
Urol Oncol; 2023 Sep; 41(9):392.e1-392.e9. PubMed ID: 37442742
[TBL] [Abstract] [Full Text] [Related]
14. Multimodal recurrence scoring system for prediction of clear cell renal cell carcinoma outcome: a discovery and validation study.
Gui CP; Chen YH; Zhao HW; Cao JZ; Liu TJ; Xiong SW; Yu YF; Liao B; Cao Y; Li JY; Huang KB; Han H; Zhang ZL; Chen WF; Jiang ZY; Gao Y; Han GP; Tang Q; Ouyang K; Qu GM; Wu JT; Guo JP; Li CX; Li PX; Liu ZP; Hsieh JT; Cai MY; Li XS; Wei JH; Luo JH
Lancet Digit Health; 2023 Aug; 5(8):e515-e524. PubMed ID: 37393162
[TBL] [Abstract] [Full Text] [Related]
15. Integrating On-Treatment Modified Glasgow Prognostic Score and Imaging to Predict Response and Outcomes in Metastatic Renal Cell Carcinoma.
Saal J; Bald T; Eckstein M; Ralser DJ; Ritter M; Brossart P; Grünwald V; Hölzel M; Ellinger J; Klümper N
JAMA Oncol; 2023 Aug; 9(8):1048-1055. PubMed ID: 37347489
[TBL] [Abstract] [Full Text] [Related]
16. Contemporary care patterns in the management of small renal masses.
Mendhiratta N; Hong BD; Johnson D; Sharma V; Baecker AS; Osuji TA; Shuch B; Gould ME
Am J Manag Care; 2023 May; 29(5):e143-e148. PubMed ID: 37229788
[TBL] [Abstract] [Full Text] [Related]
17. Comparison of patients with renal cell carcinoma in adjuvant therapy trials to a real-world population.
Millan B; Breau RH; Mallick R; Wood L; Rendon R; Finelli A; So AI; Lavallée LT; Pouliot F; Bhindi B; Heng D; Drachenberg D; Tanguay S; Dean L; Basappa NS; Lattouf JB; Bjarnason G; Lalani AK; Kapoor A
Urol Oncol; 2023 Jul; 41(7):328.e15-328.e23. PubMed ID: 37202328
[TBL] [Abstract] [Full Text] [Related]
18. Neglected lymph nodal metastases in patients with renal cancer: when to extend the anatomical template of lymph node dissection during nephrectomy.
Rosiello G; Scilipoti P; Larcher A; Fallara G; Colandrea G; Basile G; Re C; Tian Z; Karakiewicz PI; Mottrie A; Trevisani F; Marandino L; Raggi D; Necchi A; Bertini R; Salonia A; Briganti A; Montorsi F; Capitanio U
World J Urol; 2023 Jun; 41(6):1573-1579. PubMed ID: 37148324
[TBL] [Abstract] [Full Text] [Related]
19. Does Utilizing IRIS, a Segmented Three-dimensional Model, Increase Surgical Precision During Robotic Partial Nephrectomy?
Iarajuli T; Caviasco C; Corse T; Kim K; Nguyen J; De La Rosa RS; Gelman S; Spagnuolo N; Sidoti H; Miller M; Stifelman M
J Urol; 2023 Jul; 210(1):171-178. PubMed ID: 37027312
[TBL] [Abstract] [Full Text] [Related]
20. The shrinkage effect of formalin on renal cell carcinoma: Does it change the stages.
Akgul M; Arslan AI; Yazici C; Altin E; Oznur M
J Pak Med Assoc; 2022 Nov; 72(11):2175-2179. PubMed ID: 37013281
[TBL] [Abstract] [Full Text] [Related]
[Next]
